BELLUS Health Inc (BLU) - Financial and Strategic SWOT Analysis Review

Market Overview

BELLUS Health Inc (BLU)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BELLUS Health Inc (BELLUS Health) is a clinical-stage biopharmaceutical company that focuses on developing novel threapetuics for treating patients with chronic cough and hypersensitization-related disorders. The company's lead product, BLU-593 (formerly NEO5937) is a potent, orally bio-available, highly selective small molecule antagonist of the P2X3 receptor which is being developed for treating chronic cough. It has license agreement and collaborations with NEOMED institute and Parteq for the development and commercialization of BLU-593. BELLUS Health has completed the Phase I trials of BLU-593 and is planning to initiate a Phase II study in patients suffering with refractory unexplained chronic cough. BELLUS Health is headquartered in Laval, Quebec, Canada.

BELLUS Health Inc Key Recent Developments

May 08,2019: BELLUS Health reports financial and operating results for the first quarter ended march 31, 2019

Feb 21,2019: BELLUS Health presents 2018 highlights and 2019 corporate plan

Aug 08,2018: BELLUS Health reports financial and operating results for the second quarter ended june 30, 2018

May 15,2018: BELLUS Health Announces Financial Results for the First Quarter Ended March 31, 2018

Feb 21,2018: BELLUS Health Reports Financial and Operating Results for the Year Ended December 31, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Scope

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

BELLUS Health Inc-Key Facts

BELLUS Health Inc-Key Employees

BELLUS Health Inc-Key Employee Biographies

BELLUS Health Inc-Major Products and Services

BELLUS Health Inc-History

BELLUS Health Inc-Company Statement

BELLUS Health Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

BELLUS Health Inc-Business Description

BELLUS Health Inc-SWOT Analysis

SWOT Analysis-Overview

BELLUS Health Inc-Strengths

BELLUS Health Inc-Weaknesses

BELLUS Health Inc-Opportunities

BELLUS Health Inc-Threats

BELLUS Health Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

BELLUS Health Inc, Recent Deals Summary

Section 5-Company's Recent Developments

May 08, 2019: BELLUS Health reports financial and operating results for the first quarter ended march 31, 2019

Feb 21, 2019: BELLUS Health presents 2018 highlights and 2019 corporate plan

Aug 08, 2018: BELLUS Health reports financial and operating results for the second quarter ended june 30, 2018

May 15, 2018: BELLUS Health Announces Financial Results for the First Quarter Ended March 31, 2018

Feb 21, 2018: BELLUS Health Reports Financial and Operating Results for the Year Ended December 31, 2017

Jan 09, 2018: BELLUS Health Receives Milestone Payment from Taro Pharmaceuticals

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

BELLUS Health Inc, Performance Chart (2014-2018)

BELLUS Health Inc, Ratio Charts

BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

BELLUS Health Inc, Key Facts

BELLUS Health Inc, Key Employees

BELLUS Health Inc, Key Employee Biographies

BELLUS Health Inc, Major Products and Services

BELLUS Health Inc, History

BELLUS Health Inc, Subsidiaries

BELLUS Health Inc, Key Competitors

BELLUS Health Inc, Ratios based on current share price

BELLUS Health Inc, Annual Ratios

BELLUS Health Inc, Annual Ratios (Cont...1)

BELLUS Health Inc, Interim Ratios

BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

BELLUS Health Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

You can also purchase parts of this report. Do you want to check out a section wise price list?
Thank You for submiting the form our team will reach you withing next 24 hours.
85% of our clients seek customized reports. How do you wish us to custom yours?


Products

Products

BELLUS Health Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Univalor Inc

Proclara Biosciences Inc

Pfizer Inc

Genzyme Corp

FoldRx Pharmaceuticals Inc

Testimonial